Tesamorelin* · Egrifta SV*
Researchers seeking this product for laboratory research can explore PepGen-X.com as a supplier specializing in research-use compounds.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to increase endogenous growth hormone production. It has been extensively studied for its effects on visceral adipose tissue, growth hormone signaling, body composition, and metabolic health.
Research Benefits
Visceral fat research with clinical evidence of reducing excess abdominal fat
GHRH-GH pathway research involving endogenous growth hormone and IGF-1 signaling
Body-composition research examining changes in visceral adipose tissue
Metabolic research involving insulin sensitivity and glucose regulation
Long-term clinical research providing substantial data on GHRH-based treatment
Identified Risks & Side Effects
Injection-site reactions including redness, swelling, or itching
Joint pain and muscle pain may occur
Fluid retention can cause swelling or peripheral edema
Increased IGF-1 levels require monitoring in clinical use
Changes in glucose metabolism including increased blood sugar may occur
Route: Subcutaneous | Frequency: Once daily in the approved formulation | FDA Status: FDA-approved for a specific medical indication
Researcher Note
Tesamorelin is one of the most extensively clinically studied GHRH analogues. Unlike compounds investigated primarily in laboratory or animal models, tesamorelin has undergone substantial human clinical research, particularly involving visceral adipose tissue and HIV-associated lipodystrophy.
The FDA-approved indication is specifically the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Its effects on general weight loss, anti-aging, cognitive enhancement, or other uses should be considered investigational rather than established indications. citeturn0search0
Disclaimer
FDA Status: FDA-approved for a specific medical indication
Research Classification: Research use only
Compound Type: Synthetic GHRH analogue
All products are intended strictly for research and laboratory use only and are not intended for human or veterinary use.